Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer.

Technical, practical, and study design considerations are essential to maximize information obtained in limited pre-diagnostic samples of cancer patients. This study provides a framework that estimates biological effect sizes critical for consideration in designing studies for pre-diagnostic blood-based biomarker detection.